PDS Biotechnology Corporation (PDSB)

PDS Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	31.87	41.69	56.56	73.82	65.24	28.84
Cash & Short-Term Investments	31.87	41.69	56.56	73.82	65.24	28.84
Cash Growth	-44.79%	-26.29%	-23.38%	13.15%	126.23%	137.13%
Prepaid Expenses	1.77	3.36	2.49	2.66	1.6	1.5
Total Current Assets	33.65	45.05	59.06	76.48	66.84	30.34
Property, Plant & Equipment	0.27	0.3	0.34	0.53	0.36	0.55
Other Long-Term Assets	6.55	-	-	-	-	-
Total Assets	40.48	45.36	59.39	77.01	67.2	30.89
Accounts Payable	4.5	1.68	6.98	1.22	1.31	1.42
Accrued Expenses	1.48	2.84	2.42	8.31	2.19	1.74
Short-Term Debt	5.5	12.5	4.17	-	-	-
Current Portion of Leases	0.05	0.06	0.06	0.29	0.26	0.12
Total Current Liabilities	11.53	17.09	13.63	9.82	3.76	3.27
Long-Term Debt	12.94	9.2	19.51	23.02	-	-
Long-Term Leases	0.04	0.06	0.12	0.16	0.23	0.49
Total Liabilities	24.52	26.35	33.26	33.01	3.99	3.76
Common Stock	0.02	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	215.98	201.1	170.62	145.55	123.9	70.91
Retained Earnings	-200.03	-182.11	-144.5	-101.56	-60.7	-43.79
Shareholders' Equity	15.96	19	26.13	44	63.21	27.13
Total Liabilities & Equity	40.48	45.36	59.39	77.01	67.2	30.89
Total Debt	18.54	21.83	23.85	23.47	0.49	0.61
Net Cash (Debt)	13.34	19.86	32.71	50.35	64.75	28.23
Net Cash Growth	-60.02%	-39.28%	-35.03%	-22.25%	129.38%	132.12%
Net Cash Per Share	0.33	0.54	1.06	1.76	2.53	1.69
Filing Date Shares Outstanding	46.63	45.4	36.68	30.72	28.45	22.26
Total Common Shares Outstanding	46.63	37.99	33.09	30.17	28.45	22.26
Working Capital	22.12	27.97	45.43	66.66	63.08	27.07
Book Value Per Share	0.34	0.50	0.79	1.46	2.22	1.22
Tangible Book Value	15.96	19	26.13	44	63.21	27.13
Tangible Book Value Per Share	0.34	0.50	0.79	1.46	2.22	1.22
Machinery	-	0.3	0.27	0.12	0.12	0.12

Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q